{"a":[{"_":"Whitehawk swoops in for five ADCs via development deal with China's Biocytogen","$":{"href":"/biotech/whitehawk-swoops-five-adcs-development-deal-biocytogen","hreflang":"en"}}]}

Summary

Whitehawk Therapeutics and Biocytogen have entered into a development deal to create bispecific antibody-drug conjugates using Biocytogen's discovery platform. The partnership involves five ADC programs in development.